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Abstract
Introduction
The UK government advocates person-centred healthcare which is ideal for supporting
patients to make appropriate lifestyle choices and to address non-adherence. The Commu-
nity Pharmacy Future group, a collaboration between community pharmacy companies and
independents in the UK, introduced a person-centred service for patients with multiple long-
term conditions in 50 pharmacies in Northern England.
Objective
Describe the initial findings from the set up and delivery of a novel community pharmacy-
based person-centred service.
Method
Patients over fifty years of age prescribed more than one medicine including at least one for
cardiovascular disease or diabetes were enrolled. Medication review and person-centred
consultation resulted in agreed health goals and steps towards achieving them. Data were
collated and analysed to determine appropriateness of patient recruitment process and
quality of outcome data collection. A focus group of seven pharmacists was used to ascer-
tain initial views on the service.
Results
Within 3 months of service initiation, 683 patients had baseline clinical data recorded, of
which 86.9% were overweight or obese, 53.7% had hypertension and 80.8% had high car-
diovascular risk. 544 (77.2%) patients set at least one goal during the first consultation with
120 (22.1%) setting multiple goals. A majority of patients identified their goals as improve-
ment in condition, activity or quality of life. Pharmacists could see the potential patient bene-
fit and the extended role opportunities the service provided. Allowing patients to set their
own goals occasionally identified gaps to be addressed in pharmacist knowledge.
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Conclusion
Pharmacists successfully recruited a large number of patients who were appropriate for
such a service. Patients were willing to identify goals with the pharmacist, the majority of
which, if met, may result in improvements in quality of life. While challenges in delivery were
acknowledged, allowing patients to identify their own personalised goals was seen as a pos-
itive approach to providing patient services.
Introduction
Whilst the concept of person-centred care, where patients set their own health goals is well
accepted [1–4], there has been a recent increase in focus on the topic within the UK National
Health Service (NHS) [5, 6]. The United Kingdom (UK) Government has stated that patients
should be actively involved in their care with the concept of shared decision making at the
heart of NHS services and putting patients’ needs at the centre of any intervention they are
undergoing [7]. Key aspects involved in a person-centred approach include listening to the
individual to understand their perspective, providing information in a manner which enables
the person to make informed decisions and supporting them to develop goals relating to their
lifestyle, health and medicines [5–7].
In England, coronary heart disease (CHD) results in 100,000 deaths per annum with 1.5
million suffering from angina and 275,000 suffering heart attacks [8]. However, up to 50% of
cardiovascular deaths may be prevented through interventions which target modifiable risk
factors such as hypertension, cholesterol, smoking, obesity and physical exercise [8]. People
displaying some of these risk factors are also more likely to experience other co-morbidities
e.g. type 2 diabetes, asthma and chronic back pain [9].
NHS statistics suggest that many patients do not achieve health related targets for CHD [10,
11] and this is due to sub-optimal prescribing, non-adherence to treatment and inappropriate
lifestyle choices not being addressed with support from healthcare professionals. A review
relating to cardiovascular patients demonstrated that only 63% of patients continued with
their medication after one year [12]. Evidence also demonstrates that only 16% of patients pre-
scribed a new medicine take it as prescribed, experience no problems and receive as much
information as they need, whilst ten days after starting a medicine, almost one-third of patients
are non-adherent [13].
With a need to prescribe according to evidence based guidelines [14–16], to increase the
likelihood of patients taking their medicines as agreed with the prescriber [17] and provide
support to address inappropriate lifestyle choices, the community pharmacist, who will regu-
larly supply medicines to such patients, is ideally located to provide such a service. The special-
ist knowledge held by community pharmacists can be used to improve pharmaceutical care
whilst a person-centred approach is ideal for addressing non-adherence and supporting
patients to make appropriate lifestyle choices.
Person-centred care can be provided by community pharmacists when delivering interven-
tions to improve public health such as smoking cessation clinics, weight management clinics
and sexual health services. It can also be used to structure adherence focussed services relating
to the initiation of new medicines and medicines use reviews. The appearance of consultation
rooms in over 95% of community pharmacies in the UK [18] means that extended consulta-
tions can now be undertaken in a private environment which allows the pharmacist to focus
purely on the patient in front of them.
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The application of person-centred approaches is however currently untested in community
pharmacy and potential enablers, barriers and outcomes are unknown. This is also the first
UK community pharmacy service to provide such comprehensive care over a long period.
Therefore, there is a need to learn from the implementation of a new person-centred commu-
nity pharmacy service and to ascertain its feasibility.
This paper will focus on describing a new person-centred community pharmacy service,
reporting initial recruitment and consultation data and pharmacist opinions regarding imple-
mentation and delivery of such an approach.
Method
Approval for this service evaluation was provided by the Faculty of Medicines and Health Sci-
ences Ethics Committee at the University of East Anglia (UEA) before commencement.
Patients were asked to provide written consent to participate. This information was retained in
the pharmacy.
Setting
The Community Pharmacy Future (CPF) team is a partnership of four multiple pharmacy
companies (Boots UK, LloydsPharmacy, Rowlands Pharmacy and Well) that came together to
develop and implement new services in community pharmacies at their own expense. Fifty-
two community pharmacies located in Northern England were asked by the CPF team to pro-
vide the service, with ten pharmacies selected from each of the four companies plus twelve
invited that were either independent pharmacies or supermarkets. This location was chosen
due to the active pharmacy primary care research team in the area, good working relationships
with medical practices, broad representation of all CPF partners and is broadly representative
of the UK.
Participating community pharmacists were encouraged to contact the medical practices
most closely associated (in terms of prescription flow) with their pharmacy to highlight the ser-
vice to them and engage with them at an early stage. A co-ordinated approach was used to
engage medical practices associated with multiple participating pharmacies to avoid duplicat-
ing visits.
Training
All community pharmacists completed an in-house CPF-developed training package which
included a one day face-to-face training session for them and a member of their pharmacy
support team on:
• Service specification
• Measurement of blood pressure and cholesterol
• Completion of the pharmacy care record and patient care plan
• Consultation skills
It was assumed that community pharmacists would be able to appropriately respond to any
identified public health needs such as smoking cessation, weight loss and nutritional advice.
Patient eligibility
Eligible patients were identified by the community pharmacy providing the service according
to the criteria listed below:
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Inclusion criteria
• Age> 50 years
• Patient prescribed more than one including one or more drugs from British National For-
mulary chapter 2 (cardiovascular) or 6.1 (diabetes)
• Consent to participate provided
Exclusion criteria
• Previously experienced a myocardial infarction, transient ischaemic attacks (TIA), angina or
stroke. These patients were excluded as the measure of cardiovascular risk cannot be calcu-
lated in these patients.
The patient was identified from their pharmacy medication record (PMR) and when they pre-
sented to collect their dispensed prescription they were given information about the service. If
they agreed to participate, they were asked to sign a consent form. An appointment was then
arranged with the pharmacist, ideally within one week. Once consented, the patient was asked
to complete the initial questionnaire which formed the basis of the first consultation. A dia-
grammatic representation of the service is shown in Fig 1. Clinical data (height, weight, blood
pressure and cholesterol) for the service were collected by the healthcare assistant prior to
meeting with the pharmacist.
Patient questionnaire
The questionnaire used before the initial consultation, which was designed to be of a minimal
length in order to maximise patient engagement in the service, contained the following
measures:
• Quality of life measure (EuroQol EQ-5D-5L) [19]
• Patient reported medication adherence (Morisky MMAS-8) [20–22]
• Patient Activation Measure (PAM 10 item version), designed to measure patient knowledge,
skills and confidence to manage their health [23]
• Four healthcare utilisation questions
• Two demographic questions regarding smoking and ethnicity
These measures will be further discussed in subsequent publications focussing on
outcomes.
Pharmacy Care Plan (PCP) service
The Pharmacy Care Plan (PCP) service was designed to have a holistic person centred focus
and therefore not disease specific. The intervention which was focussed on patients prescribed
multiple medications was designed to both enhance the effectiveness of the patient’s medicines
and to improve lifestyle in order to improve their quality of life. The process involved an initial
medication review followed by a consultation with the patient. Support staff in some pharma-
cies contributed to patient recruitment, organisation of appointments and data collection.
Medication review. Prior to meeting the patient, the pharmacist conducted an initial
paper-based medication review from information held on the PMR. They reviewed prescrib-
ing using National Institute for Health and Care Excellence (NICE) guidance for the relevant
UK Pharmacy Care Plan service
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conditions being treated [14–16]. For older patients (>65 years) the pharmacist used a modi-
fied STOPP/START tool [24] (appropriate for use in the community pharmacy setting and
used in a previous service [25]) to enable them to structure their medication review. Addition-
ally, they reviewed the risk/benefit of all medicines with respect to falls prevention.
Fig 1. Patient flow through the PCP service.
https://doi.org/10.1371/journal.pone.0174500.g001
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Patient consultation. The medication review was followed by a face-to-face consultation
with the patient and the joint production of a personalised care plan. At the first consultation
the pharmacist or member of the pharmacy team obtained patient data to allow the calculation
of the patient’s cardiovascular risk using the QRisk2 (2016) instrument [26]. The pharmacist
then discussed and agreed the items listed in figure one to inform the development of a per-
sonalised patient care plan. The pharmacist supported patients to create their own personal-
ised health goals and then agreed actions with the patient and plans for follow up and
monitoring, including the use of validated tools to support the process [19, 20, 23]. The cate-
gorisation of these goals on the service database was open to interpretation by the pharmacist
who could categorise any goal in a way that they felt was most appropriate. Any referrals to the
patient’s GP were communicated using a standardised GP referral form which the pharmacist
sent directly to the medical practice.
Further service provision. Post-initial consultation the pharmacist subsequently under-
took brief consultations with the patient at regular intervals to discuss progress, provide fur-
ther advice and conduct follow-up monitoring. This took place when the patient attended the
pharmacy to obtain their dispensed repeat prescriptions or as necessary (nominally every two
months). Two formal follow-up appointments were planned at six and twelve months after the
initial meeting to monitor progress. The data from these interim, six and twelve month consul-
tations will be analysed and reported in subsequent papers.
The initial consultation was predicted to last 40 minutes with subsequent consultations
lasting from 15–25 minutes depending on whether these were interim or data collection
consultations.
Evaluation of pharmacists’ opinions
After the initial patient consultation a focus group was undertaken with pharmacists who were
providing the PCP service to explore their thoughts on the intervention and how they had
implemented it within their pharmacy.
Focus groups allow participants to share and clarify their own experiences by responding to
others views leading to more detailed responses than survey methods [27]. This approach
helped ensure a thorough exploration of pharmacist’s opinions within this study. The focus
group was held at a CPF pharmacist feedback event in West Yorkshire in September 2015. A
convenience sample of two pharmacists from each company were invited, as well as two inde-
pendent pharmacists (due to pharmacist professional commitments). The focus group was led
by a pharmacist qualitative researcher from UEA (MT), with experience in conducting inter-
views and focus groups, and was assisted by a non-pharmacist research manager from the CPF
group (CK). Topics discussed were developed using the Theoretical Domains Framework
(TDF) [28] and covered:
• Training provided for the service
• Recruitment and consent procedures
• Delivering the service in the context of their routine practice
• Staff involvement and interaction with other healthcare professionals
• Feedback for future service delivery
The focus group was audio recorded and transcribed verbatim. The transcription accuracy
was checked by a second researcher.
UK Pharmacy Care Plan service
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Data analysis
Data collected as part of the PCP service was entered by pharmacists on to a standard phar-
macy service database used routinely in community pharmacy in the UK. Anonymised data
were transferred to the UEA team from the service database for analysis.
Quantitative analysis. The data from the PCP service and completed questionnaires were
collated and entered on separate SPSS databases (Statistical Software for Social Sciences ver-
sion 22). Data were assessed for accuracy via visual, range and logic checks. Descriptive statis-
tics were used to describe quantitative data: mean and standard deviation for interval data,
median and interquartile ranges for ordinal or skewed interval data, and number and percent
for nominal data.
Qualitative analysis. A framework analysis approach was used [29] which involved five
key stages: familiarisation (listening to the interview, transcribing and reading transcripts),
identifying a framework, indexing, charting, mapping, and interpretation. Analysis of the tran-
script involved indexing pharmacists’ speech according to one or more of the 14 TDF domains
[28] and then grouping anonymised quotes from pharmacists into their relative TDF domains
e.g. beliefs about consequences. This was first completed by three researchers and then dis-
cussed within the group to ensure interpretation was clear. Any discrepancies were highlighted
and perceptions of the domains discussed to ensure the framework was being applied to the
transcript consistently. The 14 TDF domains were used for further abstraction into overarch-
ing themes as the same passage of text was often included in multiple TDF domains.
Results
Patient data
Recruitment into the pharmacy care plan service (PCP) took place from the 2nd February 2015
to 7th June 2015. In total 866 patients expressed an interest in the service from 48 community
pharmacies, resulting in a mean recruitment rate of 1.1 patients per pharmacy per week. Of
these, 683 patients in 42 pharmacies had the first consultation with the pharmacist and com-
pleted the baseline questionnaire. The remaining 183 patients were assumed to have with-
drawn from the service. Reasons for withdrawal were collected from 49/183 (26.8%) and
included patients ‘not having time for the service’ (20/49), ‘not needing the service’ (10/49)
and ‘not wanting to be bothered again’ (9/49). The mean (SD) age of patients at the first con-
sultation was 67.7 (8.6) with 380 (55.6%) women participating in the service. The figures for
the drop-outs were 67.0 (9.2) and 96 (52.5%) respectively. Of those participating in the first
consultation, 665 (97.4%) were white, 427 (62.5) were non-smokers (never smoked) and 177
(25.9%) were ex-smokers.
Table 1 illustrates that the majority of patients recruited to the study were overweight or
obese (86.9%), had hypertension, defined as blood pressure>140/90 mmHg, (53.7%) and a high
(>20%) QRisk2 score (80.8%). In total, 683 (100%) patients completed the patient activation
measure, MMAS-8 and the initial EQ-5D-5L assessment. Raw data is displayed in S1 Dataset.
In total, 544 (77.2%) patients set at least one goal during the first consultation with 120
(22.1%) setting multiple goals. The majority of the goals were categorised as wanting an
improvement in activity or quality of life (35.5%), improvement in condition (27.9) and reduc-
tion in symptoms (9.6%). Table 2 provides greater detail on the type of goals agreed.
Focus group
Seven pharmacists from four companies attended the focus group, which lasted approximately
90 minutes. All had provided the PCP service in their pharmacies and were in the process of
UK Pharmacy Care Plan service
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arranging the six monthly reviews for their patients. Information emerged relating to twelve of
the TDF domains with the only ones not represented being ‘intentions’ and ‘memory, atten-
tion and decision processes’. Illustrative quotes aligned with the TDF domains are provided in
Table 3 with an explanation of the overarching themes described below.
Training for the service. Pharmacists were positive regarding the consultation skills
training which had been provided and recognised the need to practise when they returned to
the pharmacy in order to become competent at delivering the service. To address this some
Table 1. Clinical data for patients completing the initial stages of the PCP service.
Clinical measure (N = 683) Measure Result
Weight (Kg) Mean (SD) 84.3 (18.6)
BMI (Kg/m2) Underweight N (%) 2 (0.3)
Healthy N (%) 87 (12.7)
Overweight N (%) 242 (35.4)
Obese N (%) 352 (51.5)
Systolic BP (mmHg) Mean (SD) 140.5 (18.3)
Diastolic BP (mmHg) Mean (SD) 78.8 (10.8)
Hypertension (≥140/90mmHg) N (%) 367 (53.7)
Total cholesterol (mmol/L) Mean (SD) 4.0 (1.2)
HDL cholesterol (mmol/L) Mean (SD) 1.3 (0.6)
QRisk2 score Mean (SD) 20.8 (13.1)
High QRisk2 score N (%) 552 (80.8)
Diagnosed conditions Diabetes* N (%) 265 (38.8); 227 (33.2) type 2
CKD N (%) 10 (1.5)
AF N (%) 30 (4.4)
RA N (%) 72 (10.5)
Angina in a 1st degree relative <60 N (%) 104 (15.2)
BP: blood pressure; HDL: High density lipoprotein; CKD: chronic kidney disease; AF: atrial fibrillation; RA: rheumatoid arthritis;
*Both type 1 and type 2 diabetes.
https://doi.org/10.1371/journal.pone.0174500.t001
Table 2. Goals agreed as part of the service.
Goal category N % (of patients = 544)
Improvement in activity or quality of life 254 46.7
Improvement in condition 200 36.8
Reduction in symptoms 69 12.7
Use of medication 44 8.1
Emotional improvement 37 6.8
Information seeking 27 5.0
Other: 83 15.3
Weight 41 7.5
Diet 14 2.6
None 8 1.5
Exercise 7 1.3
Smoking 6 1.1
Maintain 6 1.1
Other 1 0.2
Total 714
https://doi.org/10.1371/journal.pone.0174500.t002
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Table 3. TDF domains, illustrative quotes and explanations.
TDF domain Illustrative quote
Knowledge • “Lifestyle as well, I personally felt a little bit out of depth because we’ve never been fully trained on lifestyle. . . and I was like
ok, so I go to the gym, what did I google myself, what did I do myself for myself, so like that.” Ph6
Skills • “I cheated you see, I got my [relative] to be my first one. She’s a brilliant, like poorly controlled diabetes, so, you know, she
could have benefited from it, but that was like, having someone who I knew, who it didn’t really matter if I screwed up on it.”
Ph7
Social/professional role and
identity
• “Knowing that information [HbA1c] would be useful but, like I say, at the practice next door, if it’s high then they do something
about it. . . So for us to see it would be useful, from our perspective but we wouldn’t really do an awful lot with it because the
nurse next door is doing, the diabetic nurse is dealing with that kind of thing. . . So it’s kind of duplicating people doing the
same thing really.” Ph1
Beliefs about capabilities • “I don’t think I felt fully confident after my first, until after my first consultation. [Ph1 agrees]. That’s why I always explain to the
person, he was my first so I told him [laughter amongst group].” Ph5
• “I mean initially, occasionally I would get some, I mean X would come in and do a little bit [pharmacist cover] if I had a few
patients booked in, but yes it has been a struggle fitting everything in and like I said, managing patients is difficult.” Ph3
• “The problem with the goals was that the goals were anything, lifestyle, anything. If it had been, if it’d narrowed the field down
and you can sort of like say like it’s going to be diet, it’s going to be exercise or whatever maybe you could sort of like focus in
on that, but some of them were some really. . .” Ph1
Optimism • “it got you feeling a bit like motivated at the end of the day, like ‘yeh we can do this’.” Ph6
• “it was kind of exciting to be part of something that you know kinda shapes something that could be rolled out in the future”
Ph4
Beliefs about consequences • “. . .it was like, let the patient decide the goals, which is fine, because you don’t want them to do something you want them to
do, they’ve got to decide, that’s fine. But that makes it so broad. . . So, yeh, you ended up with any sort of goal, from a lot of
people just wanting to do the obvious thing like lose weight and like other people who wanted to do like slightly different
things. . . It’s quite broad.” Ph2
• “. . .we had a lot of emphasis on ‘you have to get patients who’s going to stick with this’ so then I picked kind of really regular
customers who always want a chat anyway, and that was kind of what I was told to do. But then they are not necessarily the
people who are going to benefit from it the most [agreement].” Ph7
Reinforcement • “. . .my staff initially they were like ‘we’re not getting paid for it, so why are we doing it’ but I was like ‘no but you know, it’s for
human kind’, but they don’t even see that do they?” Ph6
Goal setting • “. . .for the first reviews I would have 10 patients one month and 10 patients the next month, so to take that pressure off myself.
So, just to fit in a couple a week isn’t as much as trying to fit in 20 over 2 weeks.” Ph3
Environmental context and
resources
• “I think even with 20 though, that’s 20 hours of work that you’re supposed to fit around” Ph2 “I’d say it was more than 20
hours.” Ph7 [agreement around room] “already besides all the work you do reading things at home, writing the paperwork on
top of everything you already do. I think we were quite fortunate because our manager did attend one of the trainings and he
was like ‘there’s no way they can do this without double cover’ and we did get double cover for the initial session. I think if that
wasn’t the case I don’t think I’d have been able to do it.” Ph2
• “The healthcare assistant who I had at the training left shortly after and then you are kind of just stuck really. I had to train
other members of the staff up without really having the training myself. Ph7
• “Yeh, I really relied on NHS websites, so I. . .[cut off by 7]. . . 12 week diet plan” Ph3
Social influences • “I think initially whenever something is new it always takes a bit of time, sometimes you have to be the role model to show your
team, so like you do your first few then let them take over.” Ph5
• “What might have been a good idea is. . . getting your 10 shops together, or 10 pharmacists in a room and let them discuss
how to go about it before the consultations start. We never had that but I think that would have been a good idea. . . .but that
would have been a better sell, because if I had been able to talk to 3, then we could have gone back and yeh, first consultation
‘let’s go for it’ and know roughly how it’s going to work.” Ph5
• “I used ‘so this is a pilot scheme that the NHS is doing, you are so special like fit the criteria’, like quite a few people went with
that because they were like ‘aw, it’s for the NHS’.” Ph6
Emotion • “I think they [training team] were a very motivational team. They inspired you to do the project, and kind of showed us or told
us how important, we were an important part of the project and that makes you want to do well in it really and.” Ph3
• “It felt great, yeh, because the time and effort that you’ve put in you’ve actually seen a positive change and that, you’ve played
a part in that patient making a difference to them, because you don’t see them every day, but they see the change everyday,
they see the benefit everyday and if you can do that with every patient you can interact with it’s a good feeling.” Ph4
Behavioural regulation • “If you’ve done it [training for obtaining clinical measurements] then your team do think ‘well the pharmacist can do it’,
whereas this way, I just took a back seat on that one and let my HCA do it and then train everyone else as well so that way
they weren’t expecting me to be part of that, the metrics as well.” Ph6
https://doi.org/10.1371/journal.pone.0174500.t003
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pharmacists had undertaken further reading, some had discussed the service with colleagues
whilst others reported running a full consultation with a simulated patient, e.g. a relative,
before they felt competent. This additional reading and practise was deemed necessary to
ensure the pharmacist maintained the patient’s confidence in their ability.
One element of the training that the pharmacists were particularly supportive of was the
inclusion of other pharmacy staff. They saw this as having two primary benefits: firstly, it
allowed the staff to learn about the service and motivate them to participate when returning to
the pharmacy and secondly, it resulted in a better distribution of workload and use of skill-mix
when the service was delivered. The need for training additional staff in the pharmacy was
identified to provide cover for trained staff absences.
Pharmacists left the training sessions feeling motivated and inspired to provide the service,
seeing the benefit that it may potentially have on patients. Some pharmacists also highlighted
the effect they felt seeing their staff motivated to provide the service and that other people,
aside from just themselves, were engaged with it. With patients starting to return for their fol-
low-up consultations, pharmacists felt positive when discussing the progress they had made
with their goals. However, whilst recognising that the PCP service would be valuable for
patients, some pharmacists felt as though it was ‘another thing to do’ on top of existing heavy
workload.
Support and resources. This was a recurrent theme within the focus group and centred
on two main elements. Firstly, pharmacists highlighted the time commitment to properly
familiarise themselves with the logistics and (core) elements of the service. Many of them
described committing extra time outside of their working hours to read the documents associ-
ated with the study and practise the consultation. The main motivating factor explaining this
extra commitment relates to the earlier point about not wanting to let the patient down in the
first consultation because they were not familiar with the relevant procedures.
The second element related to resources centred on having sufficient pharmacist cover to
enable provision of the service. All of the pharmacists identified the difficulty with conducting
the initial consultations with patients (which in some cases could last up to one hour). They
reported techniques to manage their workload by staging appointments over a longer period
and asking for locum pharmacist cover to enable them to spend the time with patients. How-
ever, this cover was difficult to arrange and variable in availability.
Concerns regarding time commitment and availability of backfill was restricted to the main
(longer) consultations. They felt the shorter, interim consultation could be incorporated into
routine practice without further resources and support. However, with the additional paper-
work and data entry required for this service evaluation, pharmacists also felt that more sup-
port could be provided to enable them to complete this in a timely manner. Pharmacists
identified that if the service was to be commissioned nationally sufficient resources would
need to be provided.
Role in patient care. During the discussions, pharmacists highlighted the broad nature of
the intervention provided to patients. When they reflected on the goals that patients had set
for themselves in the initial consultation, they recognised that most of them were lifestyle
related. To some of the pharmacists, this was not particularly welcome as they likened them-
selves to a ‘weight management service’ rather than being able to utilise their expertise on med-
icines and knowledge on clinical conditions.
The selection of lifestyle related goals highlighted a training need for some of the pharma-
cists who didn’t feel confident to respond to such requests for support. As part of this service,
innovative approaches to resolving this knowledge deficiency included using trusted websites,
other colleagues or thinking about how they lived their life in order to provide information to
patients.
UK Pharmacy Care Plan service
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Pharmacists clearly described encouraging the patient to set their own goals and some
reported holding back when it came to goals that they thought were not best supported by this
particular service. They described letting the patient lead the goal setting discussion. However,
this left some pharmacists feeling lacking in confidence and underprepared for the consulta-
tion as they didn’t know what the patient was going to discuss or set as a goal prior to the
discussion.
Another element that came through the discussion was around the role of the pharmacist
within the wider healthcare team. Some pharmacists felt frustrated that they couldn’t refer
patients to other NHS services; they had to go through the medical practice. They viewed this
as increasing inconvenience for the patient. There was also discussion around access to medi-
cal notes and test results with some pharmacists wanting this information to inform the discus-
sion and goal setting with the patient. Other pharmacists said that although this information
might be useful it was the doctor’s place to deal with the test results and they didn’t want to ini-
tiate a conflict with the medical practice by ‘checking up’ on their care of the patient. There
was also an assumption that if a clinical result was abnormal on medical notes, the doctor
would have already taken care of it; a notion which was challenged by other pharmacists within
the discussion.
Some pharmacists highlighted that they managed to recruit all their patients on their own
and the referral forms were similar to those they would normally use and therefore no addi-
tional contact with the medical practice was necessary. Where pharmacists had engaged with
the medical practice at an early stage they had patients referred into the service as a result.
Those pharmacists felt that they could have more of an effect on these patients as the medical
practice had identified them as being in need of the service.
Discussion
Community pharmacists have so far recruited a large number of patients to the Pharmacy
Care Plan (PCP) service over a short period of time. From the analysis of baseline data it is
clear that there is potential for community pharmacists to have an impact on the care of these
patients as the majority are overweight or obese, have hypertension and high cardiovascular
risk. Community pharmacists have demonstrated that they are able to agree a large number of
goals with patients and that most of these focus on lifestyle and the desire to improve their
condition.
The large number recruited to this new community pharmacy service in a short space of
time indicates the willingness of patients to engage with the pharmacist and their team. The
recruitment levels are similar to those observed in previous UK community pharmacy service
evaluations [25, 30] introduced by the same organisations. Recruited patients were willing to
complete the large number of questionnaires at the beginning of the service including those on
adherence, patient activation and quality of life and the quality of data collection was excellent
which means that a robust service evaluation can be undertaken when the service is completed.
Further information on the results of these validated tools will be presented in subsequent
papers analysing the effect of the service over the course of the first six months.
From baseline data, the types of patients who were recruited into this study demonstrated
that there is a significant proportion of the population who may benefit from an intervention
of this nature and that community pharmacists can identify and recruit them. Whilst some of
the pharmacists did not believe that weight management is within their remit there is a clear
need for interventions to reduce this when the cardiovascular risk and blood pressure in such
patients was so high. Losing weight and increasing physical activity are recommended as first
line interventions for patients with high cardiovascular risk and are preferable to medicines
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initiation [14–16]. Being able to signpost patients to such services could enhance the effective-
ness of this intervention with the pharmacist playing a monitoring and motivational role when
patients collect their medicines.
In general, pharmacists in the focus group appeared motivated and engaged in providing
this new service to patients. They identified the importance of the consultations skills training
in order to provide a person-centred intervention which may in be part due to a recently
released national training package aimed at improving these skills [31]. During the discussion,
pharmacists stated that they resisted the need to suggest goals to patients and let patients lead
the consultation. It was clear that by allowing patients to set their own goals the pharmacists
reported not feeling confident when providing lifestyle advice and some were unsure as to
whether this should form part of their professional role. This confusion over professional role
is something that has previously been highlighted in the literature and is not uncommon for
pharmacists working in the community setting [32].
Whilst the results from this initial evaluation could be used to inform the design of a train-
ing package to support pharmacists when providing this service the wide variety of goals
which were selected may make this impractical. It may be that the role of the pharmacist is to
provide the intervention themselves where possible and to encourage appropriate lifestyle
changes and signpost patients to services where they could be better supported and then moni-
tor their adherence to these recommendations. Local public health focussed services commis-
sioned in community pharmacy may be beneficial so that following the identification of
patients health goals, patients could be directly enrolled in a service specific for their needs,
often delivered by another member of the pharmacy team.
A recurring theme throughout the discussion was the ability to perform the consultation
whilst not neglecting their other professional duties. It is not unusual for pharmacists to men-
tion this when questioned by researchers [33–35]. Pharmacists were not remunerated for pro-
viding this service and they developed strategies to allow them to perform the extended
consultations. This may be due to the novel nature of the study or as some expressed, the desire
to forward service development in community pharmacy. However, they did highlight that if
implemented nationally, remuneration would be necessary to ensure greater support could be
provided. If commissioned, the service would be funded appropriately and therefore these
concerns would potentially be overcome.
The general assertion by the group that they didn’t feel able to refer the patient to other ser-
vices may reflect the independence of the service from other primary care activities. Greater
integration of the service with other public health initiatives may have reduced the perception
of role ambiguity over what the pharmacists were allowed to do for patients without causing
conflict with the wider primary care team. Enhanced interaction with the medical practice
would increase their confidence in referring patients for other services and provide the phar-
macists with greater definition of their role of patient care.
One element to this interaction with the medical practice surrounds the use of patient data.
There is a move to give community pharmacists greater access to medical practice notes which
could have two primary benefits for pharmacy service provision. Firstly, the pharmacist could
have access to up-to-date information thereby reducing reliance on patient recall for informa-
tion such as test results. Secondly, it will potentially allow for the appropriate targeting of
patients for pharmacy services such as those who are poorly controlled. In previous studies
examining GP perceptions of community pharmacy services there has been some criticism of
identifying inappropriate patients and duplicating work already performed by the practice
[36–38]. With access to patient notes this may have the potential to overcome this problem.
Another method of overcoming duplication and role ambiguity is to involve both professions
in the training for services, the identification of patients and discussion of care plans. This may
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help the community pharmacist to identify and have confidence in their role and abilities. It
will also help the GP to see what the pharmacist can achieve with a patient under their care.
Strengths and limitations
This service included a wide range of patients with various health conditions and differing
clinical metrics e.g. blood pressure and QRisk2. However, we excluded those with certain diag-
noses e.g. myocardial infarction due to the complexity of their condition and management.
These patients may have a lower quality of life than those included in the service and this may
therefore lead to bias when the results are reported. The results for the clinical metrics also
indicate that these patients would not be classified as seriously unwell. However, this is not
necessarily a negative as patients with more serious illness are more likely to be managed
directly via the GP or hospital. The service also recruited patients who were mostly white, this
will therefore limit the generalisability of the results to other populations within the UK.
In terms of the description of the types of goals being set by patients, these figures should be
interpreted with caution. From data screening it became apparent that there was variation in
the categorisation of the same goals by different pharmacists. In order to ascertain how phar-
macists were conducting the service, appropriate fidelity testing would have been useful to
determine how pharmacists were implementing the service.
In terms of the focus group, this discussion consisted of a small, convenience sample of
pharmacists that were able to be released to attend the session. There was representation from
the main four companies involved in the CPF team, however, no pharmacists from the partici-
pating supermarkets or independents were able to attend. One risk in obtaining a small sample
size is the lack of representativeness of the varying pharmacist viewpoints. The transcript was
analysed by two of the authors who were either a pharmacist (MT) or employed by the phar-
macy company (CK). This may have had an impact on bias in terms of analysis and selection
of quotes; however, both positive and negative comments towards the service were described
which indicates that the pharmacists were not selected due to a positive bias towards their
employer. Finally, the topic guide and analysis were performed using a theoretical framework
derived from the literature and intended to improve the implementation of interventions into
routine practice. A COREQ checklist is included in S1 Table.
Conclusion
In summary, community pharmacists have managed to recruit a large number of patients to a
new person-centred service. From baseline data, it appears that they have recruited patients in
whom lifestyle and medication-related interventions would potentially have some benefit. In
the course of speaking to pharmacists, they described methods of overcoming issues regarding
implementation of the service and remained positive as they could see the potential benefit to
integrating the role of community pharmacy in the wider primary care team.
There is a move within the NHS to create more person-centred services as many patients
now have complex needs associated with multiple conditions. In this new service, the use of
agreeing goals was a new way of engaging patients to help support them through making
changes to improve their lifestyle and condition management. The focus group identified that
pharmacists were positive about the service with respect to both patient benefit and service
development and approaches which could be used to enhance service implementation and
delivery further. However, pharmacists feel adequate support and appropriate resources are
central to successful service provision. Future papers will look at the impact of this new
approach in terms of the outcome measures presented here.
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